sanjeri/E+ via Getty Images
Quick Take
Vividion Therapeutics (VVID) has filed to raise $100 million in an IPO of its common stock, according to an S-1 registration statement.
The company is a preclinical stage biopharma discovering treatment candidates…
Vividion Therapeutics Begins U.S. IPO Effort
Share this article
More News

(AD.DB.A) Investment Analysis and Advice
November 21, 2026


Why (ESLT) Price Action Is Critical for Tactical Trading
November 21, 2026




Why (EMXF) Price Action Is Critical for Tactical Trading
November 21, 2026